OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · Real-Time Price · USD
3.885
+0.075 (1.97%)
Nov 21, 2024, 2:00 PM EST - Market open
OraSure Technologies Revenue
OraSure Technologies had revenue of $39.92M in the quarter ending September 30, 2024, a decrease of -55.25%. This brings the company's revenue in the last twelve months to $224.26M, down -50.46% year-over-year. In the year 2023, OraSure Technologies had annual revenue of $405.47M with 4.64% growth.
Revenue (ttm)
$224.26M
Revenue Growth
-50.46%
P/S Ratio
1.26
Revenue / Employee
$351,509
Employees
638
Market Cap
289.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 405.47M | 17.99M | 4.64% |
Dec 31, 2022 | 387.48M | 153.81M | 65.82% |
Dec 31, 2021 | 233.67M | 61.95M | 36.08% |
Dec 31, 2020 | 171.72M | 17.12M | 11.07% |
Dec 31, 2019 | 154.61M | -27.14M | -14.93% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accolade | 441.03M |
Vanda Pharmaceuticals | 190.86M |
Lifecore Biomedical | 128.44M |
iTeos Therapeutics | 35.00M |
C4 Therapeutics | 33.67M |
uniQure | 28.59M |
Aclaris Therapeutics | 27.08M |
Lyell Immunopharma | 63.00K |
OSUR News
- 2 days ago - OraSure to Participate in Upcoming Investor Conference - GlobeNewsWire
- 14 days ago - OraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - OraSure Reports Q3 '24 Revenue of $39.9 Million - GlobeNewsWire
- 17 days ago - OraSure: An NCAV Diamond In The COVID Rough - Seeking Alpha
- 4 weeks ago - OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th - GlobeNewsWire
- 6 weeks ago - Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc - GuruFocus
- 2 months ago - OraSure Technologies Elects Jack Kenny to the Board of Directors - GlobeNewsWire
- 3 months ago - OraSure Technologies Inc (OSUR) Q2 2024 Earnings Call Transcript - Seeking Alpha